65,437 trials
Acne Vulgaris
Primary: Co-Primary Endpoint: Success Rate on Investigator's Global Assessment (IGA) From Baseline to Week 12 — 26.3; 17.3 Percentage of Participants
Acute Bronchial Obstruction, Asthma
Primary: Mean Change in Maximum Expiratory Flow From Baseline to Final Evaluation — 44; 43.67 Liters/minute
Secondary Hyperparathyroidism · Hemodialysis
Primary: The Percentage of Participants With of Hypercalcemia — 40.74; 63.33; 60.87; 65.38 Percentage of participants
Hypertension
Primary: Change From Baseline in the 24-hour Mean Systolic Blood Pressure Measured by Ambulatory Blood Pressure Monitoring. — -7.70; -10.48; -2.70 mmHg — p=0.001
Macular Degeneration · Choroidal Neovascularization
Primary: Mean Change From Baseline in Best-corrected Visual Acuity (BCVA) of the Study Eye at Month 12 — 53.7; 54.6; 54.8; 59.0 Letters
Onychomycosis
Primary: Efficacy Assessed by the Percentage of Participants With Complete Cure at the End of Study (Week 52) After Treating for 24 or 48 Weeks — 1.50; 0.77; 2.96; 0 Percentage…
Hypertension
Primary: Change From Baseline in 24-hour Mean Systolic Blood Pressure Measured by Ambulatory Blood Pressure Monitoring. — -14.93; -15.32; -11.29 mmHg — p=<0.001
Renal Transplantation
Primary: Change in Glomerular Filtration Rate Estimated by Iohexol Plasma Clearance 12 Months After Randomization Between the 2 Groups of Patients. — -4.07; 10.30 (mL/min)
Leukemia
Primary: Number of Participants Who Died, Experienced Other Serious Adverse Events (SAEs), Adverse Events (AEs) and AEs Leading to Study Drug Discontinuation. — 3; 2; 1; 1…
Inflammatory Tissue Disorder · Osteoarthritis · Avascular Necrosis
Primary: Knee Society Score Evaluation — 93.1 Average Knee Rating Score
Hypertension
Primary: Change From Baseline in the 24-hour Mean Systolic Blood Pressure Measured by Ambulatory Blood Pressure Monitoring. — -13.42; -14.53; -10.22; -11.99 mmHg — p=<0.001
Acne Vulgaris
Primary: Co-Primary Endpoint: Success Rate on Investigator's Global Assessment (IGA) From Baseline to Week 12 — 24.1; 16.4 Percentage of Participants
Transplantation Infection
Primary: Number of Participants With Biopsy-proven Acute Rejection — 21; 21 Participants
Primary Hypercholesterolemia · Mixed Hyperlipidemia
Primary: Cutaneous Bleeding Time (BT) — 478; 389 Seconds
Labor · Analgesia, Epidural
Primary: Duration of Continuing Analgesia — 28.6; 2.2; 25.8 hours — p=0.006